Phase 1 HLA-A*02:01-positive Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Study of IMC-P115C in Advanced PRAME-Positive Cancers

CancerPRAME PositiveHLA-A*02:01-positive

Immunocore Ltd140 enrolled13 locationsNCT07156136

Recruiting

Phase 1Phase 2

Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers

CancerHLA-A*02:01-positive

Immunocore Ltd600 enrolled13 locationsNCT06840119